Dave Shulman, MBA

Diagnosed in May 2023 at age 44 with limb-onset ALS, Dave Shulman quickly plugged into the ALS community and uses his strategic and commercial expertise to advocate for faster, more efficient progress toward better outcomes for all families affected by ALS. Dave proudly attended the ALS Clinical Research Learning Institute at the 2023 Annual NEALS Meeting, as well as the Patient Fellows Symposium Program at the 2023 International Symposium on ALS/MND. He currently co-chairs the NIH’s AMP ALS Natural History Study Working Group, serves on the Healey ALS Platform Trial Patient Advisory Committee, and supports the broader ALS landscape with interactive tools through his website - Analyze ALS (www.als.ceo). He resides in Summit, New Jersey, with his wife, two kids and mischievous shih tzu.